Foster Diana G, Biggs M Antonia, Phillips Kathryn A, Grindlay Kate, Grossman Daniel
Advancing New Standards in Reproductive Health, Bixby Center for Global Reproductive Health, and the Department of Obstetrics, Gynecology & Reproductive Science, University of California, San Francisco, San Francisco, CA 94143, USA.
Advancing New Standards in Reproductive Health, Bixby Center for Global Reproductive Health, and the Department of Obstetrics, Gynecology & Reproductive Science, University of California, San Francisco, San Francisco, CA 94143, USA; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA 94143, USA.
Contraception. 2015 May;91(5):373-9. doi: 10.1016/j.contraception.2015.01.010. Epub 2015 Feb 27.
This study estimates how making oral contraceptive pills (OCPs) available without a prescription may affect contraceptive use, unintended pregnancies and associated contraceptive and pregnancy costs among low-income women.
Based on published figures, we estimate two scenarios [low over-the-counter (OTC) use and high OTC use] of the proportion of low-income women likely to switch to an OTC pill and predict adoption of OCPs according to the out-of-pocket costs per pill pack. We then estimate cost-savings of each scenario by comparing the total public sector cost of providing OCPs OTC and medical care for unintended pregnancy.
Twenty-one percent of low-income women at risk for unintended pregnancy are very likely to use OCPs if they were available without a prescription. Women's use of OTC OCPs varies widely by the out-of-pocket pill pack cost. In a scenario assuming no out-of-pocket costs for the over-the counter pill, an additional 11-21% of low-income women will use the pill, resulting in a 20-36% decrease in the number of women using no method or a method less effective than the pill, and a 7-25% decrease in the number of unintended pregnancies, depending on the level of use and any effect on contraceptive failure rates.
If out-of-pocket costs for such pills are low, OTC access could have a significant effect on use of effective contraceptives and unintended pregnancy. Public health plans may reduce expenditures on pregnancy and contraceptive healthcare services by covering oral contraceptives as an OTC product.
Interest in OTC access to oral contraceptives is high. Removing the prescription barrier, particularly if pill packs are available at low or zero out-of-pocket cost, could increase the use of effective methods of contraception and reduce unintended pregnancy and healthcare costs for contraceptive and pregnancy care.
本研究评估无需处方即可获得口服避孕药(OCPs)会如何影响低收入女性的避孕措施使用情况、意外怀孕以及相关的避孕和怀孕成本。
基于已发表的数据,我们估计了低收入女性可能转而使用非处方避孕药的两种情况(低非处方使用率和高非处方使用率),并根据每包避孕药的自付费用预测口服避孕药的采用情况。然后,我们通过比较提供非处方口服避孕药的公共部门总成本与意外怀孕的医疗费用,估计每种情况的成本节约情况。
如果无需处方即可获得口服避孕药,那么21%有意外怀孕风险的低收入女性很可能会使用该药物。女性对非处方口服避孕药的使用因每包药物的自付费用而有很大差异。在假设非处方避孕药无自付费用的情况下,另外11%-21%的低收入女性会使用该药物,这将使未采取任何避孕措施或采取的避孕措施效果不如口服避孕药的女性人数减少20%-36%,意外怀孕的女性人数减少7%-25%,具体取决于使用水平以及对避孕失败率的任何影响。
如果此类药物的自付费用较低,非处方获取途径可能会对有效避孕措施的使用和意外怀孕产生重大影响。公共卫生计划可通过将口服避孕药作为非处方产品进行覆盖,来减少怀孕和避孕医疗服务的支出。
人们对非处方获取口服避孕药的兴趣很高。消除处方障碍,特别是如果药包的自付费用较低或为零,可能会增加有效避孕方法的使用,并降低意外怀孕以及避孕和怀孕护理的医疗成本。